Table of Contents
	 
	1. Executive Summary
	 
	2. Global Drug Discovery Services Market: Market Dynamics
	2.1: Introduction, Background, and Classifications
	2.2: Supply Chain
	2.3: Industry Drivers and Challenges 
	 
	3. Market Trends and Forecast Analysis from 2017 to 2028
	3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
	3.2: Global Drug Discovery Services Market Trends (2017-2022) and Forecast (2023-2028)
	3.3: Global Drug Discovery Services Market by Process
	3.3.1: Target Selection   
	3.3.2: Target Validation   
	3.3.3: Hit-to-Lead Identification   
	3.3.4: Lead Optimization   
	3.3.5: Candidate Validation   
	3.4: Global Drug Discovery Services Market by Type 
	3.4.1: Chemistry Services 
	3.4.2: Biology Services 
	3.5: Global Drug Discovery Services Market by Drug Type
	3.5.1: Small-molecule Drugs 
	3.5.2: Biologics 
	3.6: Global Drug Discovery Services Market by Therapeutic Area 
	3.6.1: Oncology   
	3.6.2: Neurology   
	3.6.3: Cardiovascular Diseases   
	3.6.4: Respiratory Diseases   
	3.6.5: Diabetes and Other Therapeutic Areas   
	3.7: Global Drug Discovery Services Market by End Users 
	3.7.1: Pharmaceutical & Biotechnology Companies   
	3.7.2: Academic Institutes   
	3.7.3: Others   
	 
	4. Market Trends and Forecast Analysis by Region from 2017 to 2028
	4.1: Drug Discovery Services Market by Region
	4.2:  North American Drug Discovery Services Market 
	4.2.1: North American Drug Discovery Services Market by Type: Chemistry Services and Biology Services 
	4.2.2: North American Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
	4.3: European Drug Discovery Services Market  
	4.3.1: European Drug Discovery Services Market by Type: Chemistry Services and Biology Services 
	4.3.2: European Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
	4.4: APAC Drug Discovery Services Market  
	4.4.1: APAC Drug Discovery Services Market by Type: Chemistry Services and Biology Services 
	4.4.2: APAC Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
	4.5: ROW Drug Discovery Services Market  
	4.5.1: ROW Drug Discovery Services Market by Type: Chemistry Services and Biology Services 
	4.5.2: ROW Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
	 
	5. Competitor Analysis  
	5.1: Product Portfolio Analysis  
	5.2: Operational Integration  
	5.3: Porter’s Five Forces Analysis   
	 
	6. Growth Opportunities and Strategic Analysis  
	6.1: Growth Opportunity Analysis   
	6.1.1: Growth Opportunities for the Global Drug Discovery Services Market by Process 
	6.1.2: Growth Opportunities for the Global Drug Discovery Services Market by Type
	6.1.3: Growth Opportunities for the Global Drug Discovery Services Market by Drug Type 
	6.1.4: Growth Opportunities for the Global Drug Discovery Services Market by Therapeutic Area 
	6.1.5: Growth Opportunities for the Global Drug Discovery Services Market by End Users 
	6.1.6: Growth Opportunities for the Global Drug Discovery Services Market by Region
	6.2: Emerging Trends in the Global Drug Discovery Services Market   
	6.3: Strategic Analysis   
	6.3.1: New Product Development   
	6.3.2: Capacity Expansion of the Global Drug Discovery Services Market   
	6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Services Market   
	6.3.4: Certification and Licensing   
	 
	7. Company Profiles of Leading Players  
	7.1: Eurofins Scientific
	7.2: Evotec SE
	7.3: Charles River Laboratories International
	7.4: GenScript
	7.5: Thermo Fisher Scientific
	7.6: Oncodesign Services
	7.7: ChemPartner Co.
	7.8: DiscoverX Corp.
	7.9: QIAGEN
	7.10: Domainex Ltd